Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9113 - 9120 of 12089 results
September Health Care Qui Tam Update
September 21, 2015| Blog| Viewpoint
President Preps for Papal Visit While DOE Announces Tech Report, Funding
September 18, 2015| Blog| Viewpoint
Supreme Judicial Court Affirms Award Of $2,250,000 plus Interest Against Insurer for Breach of Duty to Defend and Settle — on $50,000 Policy
September 18, 2015| Alert| Viewpoint
Register For Our September Webinar -- Another Cop on the Cybersecurity Beat: What to Do Before and After the SEC and FINRA Come Knocking?
September 18, 2015| Blog| Viewpoint
Thinking Big about Data – the new EDPS Ethics Board
September 18, 2015| Blog| Viewpoint
Back to School - and the SEC Cybersecurity Exams (Register now for our September Privacy Webinar!)
September 18, 2015| Blog| Viewpoint
GAO Report on EB-5 a Possible Blueprint for Lawmakers and New Legislation
September 17, 2015| Blog| Viewpoint
FDA Releases Two Final Food Safety Rules: What You Need to Know
September 17, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|